Divekar A Y
Biochim Biophys Acta. 1976 Jan 23;422(1):15-28. doi: 10.1016/0005-2744(76)90004-8.
Adenosine phosphorylase (EC 2.4.2.-) activity present in Sarcoma 180 cells grown in culture and in rat liver, is shown to be distinct from inosine-guanosine phosphorylase by several criteria: (a) treatment of Sarcoma 180 cell extract with p-chloromercuribenzoate inhibited the two activities to a different extent, (b) adenine selectively protected the adenosine phosphorylase activity of Sarcoma 180 and rat liver extract against heat inactivation, while hypoxanthine selectively protected inosine-guanosine phosphorylase activity, (c) at nearly saturating substrate concentrations and using Sarcoma 180 extract, the rates of ribosylation of a mixture of adenine + hypoxanthine or adenine + guanine, but not of hypoxanthine + guanine, were found to be almost equal to the sum of their individual rates as measured separately, (d) inosine selectively inhibited the ribosylation of hypoxanthine and guanine catalysed by Sarcoma 180 and rat liver extract while 2-chloroadenosine selectively inhibited the ribosylation of adenine and N6-furfuryladenine, (e) pH vs. activity curves were similar with hypoxanthine or guanine as the substrate but they were markedly different from the curve with adenine as the substrate. The potential role of adenosine phosphorylase activity in vivo is discussed.
培养的肉瘤180细胞和大鼠肝脏中存在的腺苷磷酸化酶(EC 2.4.2.-)活性,通过几个标准显示与肌苷 - 鸟苷磷酸化酶不同:(a)用对氯汞苯甲酸处理肉瘤180细胞提取物对两种活性的抑制程度不同;(b)腺嘌呤选择性地保护肉瘤180和大鼠肝脏提取物的腺苷磷酸化酶活性免受热失活,而次黄嘌呤选择性地保护肌苷 - 鸟苷磷酸化酶活性;(c)在接近饱和底物浓度并使用肉瘤180提取物时,发现腺嘌呤+次黄嘌呤或腺嘌呤+鸟嘌呤混合物的核糖基化速率,但次黄嘌呤+鸟嘌呤混合物的核糖基化速率几乎等于分别测量的它们各自速率之和;(d)肌苷选择性抑制肉瘤180和大鼠肝脏提取物催化的次黄嘌呤和鸟嘌呤的核糖基化,而2 - 氯腺苷选择性抑制腺嘌呤和N6 - 呋喃基腺嘌呤的核糖基化;(e)以次黄嘌呤或鸟嘌呤为底物时的pH与活性曲线相似,但与以腺嘌呤为底物的曲线明显不同。文中讨论了腺苷磷酸化酶活性在体内的潜在作用。